|
US5622871A
(en)
|
1987-04-27 |
1997-04-22 |
Unilever Patent Holdings B.V. |
Capillary immunoassay and device therefor comprising mobilizable particulate labelled reagents
|
|
US4135884A
(en)
|
1977-08-29 |
1979-01-23 |
Shen James T |
Gamma stick
|
|
US4305924A
(en)
|
1979-08-08 |
1981-12-15 |
Ventrex Laboratories, Inc. |
Method and apparatus for performing in vitro clinical diagnostic tests using a solid phase assay system
|
|
US4444880A
(en)
|
1982-07-27 |
1984-04-24 |
Syva Company |
Periodate removal of ascorbate interference in dipsticks for immunoassays
|
|
DE3856421T2
(de)
|
1987-04-27 |
2000-12-14 |
Unilever Nv |
Spezifische Bindungstestverfahren
|
|
US4943522A
(en)
|
1987-06-01 |
1990-07-24 |
Quidel |
Lateral flow, non-bibulous membrane assay protocols
|
|
AU2684488A
(en)
|
1988-06-27 |
1990-01-04 |
Carter-Wallace, Inc. |
Test device and method for colored particle immunoassay
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
WO1992012428A1
(en)
|
1991-01-11 |
1992-07-23 |
Quidel Corporation |
A one-step lateral flow nonbibulous assay
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US6824989B1
(en)
|
2000-09-01 |
2004-11-30 |
Upstate Biotechnology, Inc. |
Recombinant monoclonal antibody to phosphotyrosine-containing proteins
|
|
US6565808B2
(en)
|
2001-05-18 |
2003-05-20 |
Acon Laboratories |
Line test device and methods of use
|
|
US6902932B2
(en)
|
2001-11-16 |
2005-06-07 |
Tissue Regeneration, Inc. |
Helically organized silk fibroin fiber bundles for matrices in tissue engineering
|
|
US20110009960A1
(en)
|
2001-11-16 |
2011-01-13 |
Allergan, Inc. |
Prosthetic fabric structure
|
|
US7470428B2
(en)
|
2002-01-30 |
2008-12-30 |
The Brigham And Women's Hospital, Inc. |
Compositions and methods related to TIM-3, a Th1-specific cell surface molecule
|
|
CA2541006C
(en)
|
2003-10-03 |
2015-02-17 |
Brigham And Women's Hospital |
Tim-3 polypeptides
|
|
JP2008537551A
(ja)
|
2005-03-31 |
2008-09-18 |
カランド ファーマシューティカルズ， インコーポレイテッド |
リボヌクレオチドレダクターゼサブユニット２の阻害剤およびその使用
|
|
DK2439273T3
(da)
|
2005-05-09 |
2019-06-03 |
Ono Pharmaceutical Co |
Humane monoklonale antistoffer til programmeret død-1(pd-1) og fremgangsmåder til behandling af cancer ved anvendelse af anti-pd-1- antistoffer alene eller i kombination med andre immunterapeutika
|
|
EP3549551A1
(en)
|
2007-03-20 |
2019-10-09 |
Serica Technologies, Inc. |
Tendon prosthesis and method of manufacturing the same
|
|
WO2010001617A1
(en)
|
2008-07-04 |
2010-01-07 |
Ono Pharmaceutical Co., Ltd. |
Use of an efficacy marker for optimizing therapeutic efficacy of an anti-human pd-1 antibody on cancers
|
|
ES2893855T3
(es)
|
2011-08-11 |
2022-02-10 |
Ono Pharmaceutical Co |
Agente terapéutico para enfermedades autoinmunes que comprende agonista de PD-1
|
|
HK1203971A1
(en)
|
2012-05-15 |
2015-11-06 |
Bristol-Myers Squibb Company |
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling
|
|
PL2904011T3
(pl)
*
|
2012-10-02 |
2018-01-31 |
Bristol Myers Squibb Co |
Połączenie przeciwciał anty-kir i przeciwciał anty-pd-1 w leczeniu raka
|
|
CN112552401B
(zh)
|
2013-09-13 |
2023-08-25 |
广州百济神州生物制药有限公司 |
抗pd1抗体及其作为治疗剂与诊断剂的用途
|
|
US10034463B2
(en)
|
2014-01-24 |
2018-07-31 |
Children's Medical Center Corporation |
High-throughput mouse model for optimizing antibody affinities
|
|
US9579673B2
(en)
|
2014-06-09 |
2017-02-28 |
The Procter & Gamble Company |
Flushing dispensers for delivering a consistent consumer experience
|
|
CN105061597B
(zh)
*
|
2015-06-09 |
2016-04-27 |
北京东方百泰生物科技有限公司 |
一种抗pd-1的单克隆抗体及其获得方法
|
|
KR20180019725A
(ko)
*
|
2015-06-23 |
2018-02-26 |
메모리얼 슬로안-케터링 캔서 센터 |
신규의 피디 1 면역 조절제
|
|
MX383464B
(es)
|
2015-07-13 |
2025-03-14 |
Cytomx Therapeutics Inc |
Anticuerpos anti-pd-1, anticuerpos anti-pd-1 activables, y métodos de uso de los mismos.
|
|
BR112018006237A2
(pt)
*
|
2015-09-29 |
2018-10-09 |
Celgene Corp |
proteínas de ligação a pd-1 e métodos de uso das mesmas
|
|
JP7257967B2
(ja)
|
2017-05-01 |
2023-04-14 |
ザ チルドレンズ メディカル センター コーポレーション |
抗ｐｄ１抗体試薬に関する方法および組成物
|